1 / 5

Optimizing NDA Clinical Trials and Research | Clival Database

Clival Database empowers Clinical Trial Organizations with advanced solutions for NDA in clinical trials, ensuring seamless management and regulatory compliance. Supporting allphase clinical research, Clival streamlines data collection and analysis across clinical trial sites in India and beyond. As a trusted clinical trial research organization, it offers comprehensive insights to accelerate NDA clinical trial processes.

ClivalDatabase
Download Presentation

Optimizing NDA Clinical Trials and Research | Clival Database

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 언어선택   Glossary Term  Adverse Event A medical occurrence or a negative change that happens at the time of a clinical trial or within a speci?c period once the trial is completed, is termed as adverse event. It may or may not be caused by the treatment which is being studied.  Arm Assignment  Assessment  Blind Just Now Customer Support Hi! How can we help?  Control  I have a question Clinical study Cookies & Privacy Tell me more  Cross-over trial This website uses ‘cookies’ to operate our site and personalize your digital experience. By continuing to browse this website, you agree to the terms outlined in our Privacy Policy, Cookies Policy  Type here and press enter..    Dosing discontinuation  Double-blind 1 Accept All Customise Cookies  Early patient withdrawal (premature withdrawal)

  2. Eligibility Criteria  EMA  Enrollment  Health Authority  Indication  Informed consent  Institutional Review Board (IRB or IEC)  Interventional Study  Investigational Drug  Medication Number  Observational Study  Outcome Measure  Part  Phase  Placebo  Principal investigator  Protocol

  3. Randomized allocation  Randomization number  Run-in period  Serious adverse event  Sponsor  Study completed date  Subject  Subject Number  Variable  Wash-out period  Subscribe to get latest updates and information.  Subscribe to Our Newsletter!   Subscribe Enter your email I'm not a robot reCAPTCHA

  4. Privacy - Terms C-89, Sector-65 Noida-U.P. 201301 (India) Phone: +91-120-6631301-361 Mobile: +91-9990237670 Customer Care: 18004190155 Email: info@lifescienceintellipedia.com Email: sales@lifescienceintellipedia.com QUICK Links About Us Contact us Terms Of Use Terms & Conditions Privacy Policy Refund Policy FAQs Blog Newsletter Power BI Demo Clinipedia Glossary Terms  Drug Development Process  Therapeutic Area  Sponsor/ Organisation  Orphan Drug Designation 

  5. Fast Track Approval  Breakthrough Approval  CRO  Locate Us Lifescience Intellipedia | Regulatory … View larger map Keyboard shortcuts Map data ©2025 Terms Report a map error Copyright 2025 All right reserved, Lifescience Intellipedia Pvt. Ltd.     

More Related